Article Details
Retrieved on: 2022-06-01 18:50:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Mixed reviews followed I-Mab Biopharma Co. Ltd.'s disclosure of the latest phase II data from a 221-person trial with anti-CD73 antibody ...
Article found on: www.bioworld.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here